BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3398856)

  • 1. Biochemical and molecular characterization of the glucocorticoid receptor of lymphosarcoma P1798 variants.
    Lucas KL; Barbour KW; Housley PR; Thompson EA
    Mol Endocrinol; 1988 Mar; 2(3):291-9. PubMed ID: 3398856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of lymphosarcoma P1798 variants selected for resistance to the cytolytic effects of glucocorticoids in vivo and in culture.
    Wood KM; Thompson EA
    Mol Cell Endocrinol; 1984 Sep; 37(2):169-80. PubMed ID: 6092172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insensitivity to the cytolytic effects of glucocorticoids in vivo is associated with a novel "slow death" phenotype.
    Thompson EA
    Cancer Res; 1991 Oct; 51(20):5544-50. PubMed ID: 1913673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The truncated glucocorticoid receptor in the P1798 mouse lymphosarcoma is associated with resistance to glucocorticoid lysis but not to other glucocorticoid-induced functions.
    Ip MM; Shea WK; Sykes D; Young DA
    Cancer Res; 1991 Jun; 51(11):2786-96. PubMed ID: 1674446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid binding properties of mouse thymic lymphosarcoma cell populations selected for resistance to the cytolytic effects of glucocorticoids in vivo.
    Chan AK; Thompson EA
    J Natl Cancer Inst; 1983 Sep; 71(3):579-82. PubMed ID: 6577232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear binding of steroid-receptor complex to lymphosarcoma P1798 resistant and sensitive cells and effect of concanavalin A on receptor levels.
    McPartland RP; Milholland RJ; Rosen F
    Cancer Res; 1977 Dec; 37(12):4256-60. PubMed ID: 579163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonmutational alteration in glucocorticoid sensitivity of lymphosarcoma P1798.
    Davis JM; Chan AK; Thompson EA
    J Natl Cancer Inst; 1980 Jan; 64(1):55-62. PubMed ID: 6928047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid insensitivity of P1798 lymphoma cells is associated with production of a factor that attenuates the lytic response.
    Thompson EA
    Cancer Res; 1991 Oct; 51(20):5551-6. PubMed ID: 1913674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal regulation of transcription of rDNA. Inhibition of transcription during glucocorticoid-mediated inhibition of proliferation of lymphosarcoma P1798 cells in culture.
    Cavannaugh AH; Thompson EA
    J Biol Chem; 1983 Aug; 258(16):9768-73. PubMed ID: 6688417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A somatic cell genetic method for identification of untargeted mutations in the glucocorticoid receptor that cause hormone binding deficiencies.
    Lee S; Duncan KA; Chou H; Chen D; Kohli K; Huang CF; Stallcup MR
    Mol Endocrinol; 1995 Jul; 9(7):826-37. PubMed ID: 7476966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of a cell-culture line derived from lymphosarcoma P1798.
    Thompson EA
    Mol Cell Endocrinol; 1980 Feb; 17(2):95-102. PubMed ID: 6892700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid-resistant lymphoma cell variants that contain functional glucocorticoid receptors.
    Rabindran SK; Danielsen M; Stallcup MR
    Mol Cell Biol; 1987 Dec; 7(12):4211-7. PubMed ID: 2830485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid effects on myeloma cells in culture: correlation of growth inhibition with induction of glucocorticoid receptor messenger RNA.
    Gomi M; Moriwaki K; Katagiri S; Kurata Y; Thompson EB
    Cancer Res; 1990 Mar; 50(6):1873-8. PubMed ID: 2106390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical differences between glucocorticoid-binding components from the corticoid-sensitive and -resistant strains of mouse lymphoma P1798.
    Stevens J; Stevens YW
    Cancer Res; 1979 Oct; 39(10):4011-21. PubMed ID: 476639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid inhibition of transcription from adenovirus major late promoter.
    Mahajan PB; Thompson EA
    Mol Endocrinol; 1990 Oct; 4(10):1515-21. PubMed ID: 2283999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and localization of steroid-binding and nonsteroid-binding forms of the glucocorticoid receptor in the mouse P1798 lymphosarcoma.
    Rowan BG; Ip MM
    J Steroid Biochem Mol Biol; 1995 May; 52(5):437-50. PubMed ID: 7748809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stable overproduction of intact glucocorticoid receptors in mammalian cells using a selectable glucocorticoid responsive dihydrofolate reductase gene.
    Bellingham DL; Cidlowski JA
    Mol Endocrinol; 1989 Nov; 3(11):1733-47. PubMed ID: 2608055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sodium butyrate on glucocorticoid-sensitive and -resistant P1798 lymphosarcoma.
    Chang YF; Wu LH; Liu TY; Yang JC; Chi CW
    Zhonghua Yi Xue Za Zhi (Taipei); 1992 Jan; 49(1):1-5. PubMed ID: 1312378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of cortisol-sensitive and -resistant P1798 mouse lymphosarcoma cell lines.
    Chi CW; Sykes D; Ip MM
    Mol Cell Endocrinol; 1989 Apr; 62(2):167-76. PubMed ID: 2744225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell membrane sialoglycopeptides of corticoid-sensitive and -resistant lymphosarcoma P1798.
    Behrens UJ; Hollander VP
    Cancer Res; 1976 Jan; 36(1):172-80. PubMed ID: 946164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.